임신 중 hexyl salicylate을 피해야 할까요? | VeriMom
Hexyl salicylate has been assessed by ECHA/RAC and recommended for harmonised classification as Repr.2 (H361d, 'suspected of damaging the unborn child'), which supports a 'suspected' reproductive hazard. The mechanistic evidence for reproductive toxicity is limited (SCCS and RAC noted concerns including potential endocrine-related effects but did not identify a well-characterised molecular mechanism), so mechanism is scored as theoretical. Topical cosmetic use gives measurable systemic exposure for a lipophilic ester (log Kow ~5) and the SCCS performed exposure-driven assessments and set use/concentration limits, consistent with a moderate exposure score.
ECHA regulatory hazard statements
- •H361D
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- hexyl salicylate은 임신 중 안전한가요?
- Hexyl salicylate has been assessed by ECHA/RAC and recommended for harmonised classification as Repr.2 (H361d, 'suspected of damaging the unborn child'), which supports a 'suspected' reproductive hazard. The mechanistic evidence for reproductive toxicity is limited (SCCS and RAC noted concerns including potential endocrine-related effects but did not identify a well-characterised molecular mechanism), so mechanism is scored as theoretical. Topical cosmetic use gives measurable systemic exposure for a lipophilic ester (log Kow ~5) and the SCCS performed exposure-driven assessments and set use/concentration limits, consistent with a moderate exposure score.
- hexyl salicylate은 모유 수유 중 안전한가요?
- Because hexyl salicylate is classified Repr.2 (H361d) and is lipophilic with potential for systemic absorption after topical use, a similar 'suspected' hazard rating is applied for breastfeeding. There is no high-quality human milk transfer data or demonstrated mechanism linked specifically to lactational transfer, so mechanism is theoretical, and exposure from topical use is rated moderate (SCCS evaluated consumer exposures).
- hexyl salicylate은 아기 피부에 안전한가요?
- SCCS assessed hexyl salicylate for children 0–3 years and provided guidance/limits; combined with the harmonised Repr.2 classification the hazard remains 'suspected' for infant exposure. Mechanistic data specific to infants is lacking. Because infant skin has higher surface-area-to-weight and immature barrier function, exposure is increased by +1 (moderate→high) relative to adults for topical use — SCCS specifically considered young children in its addendum.
- VeriMom은 hexyl salicylate을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 hexyl salicylate을 20/100 (높은 위험)로 평가합니다.
- 임신 중 hexyl salicylate 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.